Ireland· IE-PA-PA23458/005/001
REVAXIS Suspension for injection in pre-filled syringe Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
A diphtherie-poliomyelitis-tetanus product containing diphtheria toxoid + tetanus toxoid + poliovirus, type 1 + poliovirus, type 2, registered in Ireland by Sanofi Winthrop Industrie. The same ATC class is registered in 5 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Diphtherie-poliomyelitis-tetanus is registered in 5 of 19 countries.
Countries holding a registration under ATC J07CA01 (diphtherie-poliomyelitis-tetanus), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Diphtherie-poliomyelitis-tetanus · ATC J07CA01
5 / 19 countries
- Belgiumprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Diphtheria toxoid + Tetanus toxoid + POLIOVIRUS, TYPE 1 + Poliovirus, type 2
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Ireland (IE)
- ATC code
- J07CA01
- ATC class
- Diphtherie-Poliomyelitis-Tetanus
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA23458/005/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07CA01
Diphtherie-poliomyelitis-tetanus, as other registers publish it.
- NetherlandsDifterie-, Tetanus-, Poliomyelitisvaccin, suspensie voor injectieBilthoven Biologicals B.V.
- PolandDultavaxSanofi Pasteur
- BelgiumRevaxisSanofi Winthrop Industrie
- SwitzerlandRevaxis
- NetherlandsREVAXiS, suspensie voor injectie in een voorgevulde spuitEuro Registratie Collectief B.V.
- NetherlandsREVAXiS, suspensie voor injectie, 0,5 mlSanofi Winthrop Industrie
- SwitzerlandRevaxis, suspension injectableSanofi-Aventis (Suisse) SA
- SwitzerlandRevaxis, suspension injectableSanofi-Aventis (Suisse) SA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5bdbc4c4-36b5-4f3d-a1c8-5b2524fa3d0b GET /v1/drugs/5bdbc4c4-36b5-4f3d-a1c8-5b2524fa3d0b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspension for injection in pre-filled syringe",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07CA01"
],
"strength": null,
"pa_number": "PA23458/005/001",
"substances": [
"Diphtheria toxoid",
"Tetanus toxoid",
"POLIOVIRUS, TYPE 1",
"Poliovirus, type 2",
"Poliovirus, type 3"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "18/02/2000",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about diphtherie-poliomyelitis-tetanus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.